IE792445L - 1,4-dihydropyridines - Google Patents

1,4-dihydropyridines

Info

Publication number
IE792445L
IE792445L IE792445A IE244579A IE792445L IE 792445 L IE792445 L IE 792445L IE 792445 A IE792445 A IE 792445A IE 244579 A IE244579 A IE 244579A IE 792445 L IE792445 L IE 792445L
Authority
IE
Ireland
Prior art keywords
compounds
dihydropyridines
gb2037766a
spasms
muscles
Prior art date
Application number
IE792445A
Other versions
IE49496B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority to IE1165/83A priority Critical patent/IE49497B1/en
Publication of IE792445L publication Critical patent/IE792445L/en
Publication of IE49496B1 publication Critical patent/IE49496B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compounds of formula I, <IMAGE> where X is oxygen or sulphur; R1 and R2 are various esterifying radicals; and R3 is H or C1-3 alkyl. The compounds are useful for treating coronary insufficiency, intermittent claudication, cerebrovascular insults, spasms in muscles and hypertension. [GB2037766A]
IE2445/79A 1978-12-18 1979-12-17 A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it IE49496B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1165/83A IE49497B1 (en) 1978-12-18 1979-12-17 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283578A CH639659A5 (en) 1978-12-18 1978-12-18 NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.

Publications (2)

Publication Number Publication Date
IE792445L true IE792445L (en) 1980-06-18
IE49496B1 IE49496B1 (en) 1985-10-16

Family

ID=4386824

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2445/79A IE49496B1 (en) 1978-12-18 1979-12-17 A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it

Country Status (18)

Country Link
JP (1) JPS5583783A (en)
AU (1) AU536055B2 (en)
BE (1) BE880591A (en)
CH (1) CH639659A5 (en)
CY (1) CY1321A (en)
DE (1) DE2949491A1 (en)
FR (1) FR2444681A1 (en)
GB (2) GB2037766B (en)
HK (1) HK16086A (en)
IE (1) IE49496B1 (en)
IT (1) IT1164097B (en)
KE (1) KE3593A (en)
MY (1) MY8500130A (en)
NL (2) NL193066C (en)
NZ (1) NZ192422A (en)
SE (1) SE445219B (en)
SG (1) SG97585G (en)
ZA (1) ZA796842B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (en) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-THIAZOLE or 4-IMIDAZOLE-SUBSTITUTED, 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM
CH655658B (en) * 1980-09-18 1986-05-15
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
FR2528431B1 (en) * 1982-06-15 1986-01-10 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
IL68975A (en) * 1982-06-15 1987-01-30 Sandoz Ag 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives in optically active form,their preparation and pharmaceutical compositions containing them
JPS5978186A (en) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
NL194389C (en) * 1984-06-14 2002-03-04 Novartis Ag Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier.
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
NL194822C (en) * 1985-10-01 2003-04-03 Novartis Ag Preparation for oral administration with controlled release and method for its preparation.
DE3542794A1 (en) * 1985-12-04 1987-06-11 Bayer Ag ANTI-HYPERTENSIVE COMBINATION PREPARATION
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
KR940003492B1 (en) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-dihydropyridine derivative and preparation method thereof
DE4222770A1 (en) * 1992-07-10 1994-01-13 Bayer Ag Light-activated 1- (2-nitrobenzyl) -substituted 1,4-dihydropyridines
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2005023787A1 (en) * 2003-09-10 2005-03-17 Shasun Chemicals And Drugs Limited Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
CN103613584B (en) * 2013-11-27 2016-04-27 沈阳药科大学 The method of a kind of Isrodipine synthetic product aftertreatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (en) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridine-33-dicarboxylic acid alkyl ester
FR2320750A1 (en) * 1975-08-12 1977-03-11 Hexachimie 1,4-DIHYDRO PYRIDINES AND THEIR THERAPEUTIC APPLICATION
DE2616991A1 (en) * 1976-04-17 1977-10-27 Bayer Ag Thio-substd. dihydro-pyridine derivs. - coronary vasodilators and antihypertensives prepd. e.g. by reacting dicarbonyl cpds. with amines and thio-substd. ketones
JPS5373327A (en) * 1976-12-13 1978-06-29 Matsushita Electric Ind Co Ltd Power source system
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES

Also Published As

Publication number Publication date
NL193066B (en) 1998-05-06
IT1164097B (en) 1987-04-08
GB2103203A (en) 1983-02-16
NZ192422A (en) 1982-09-14
GB2103203B (en) 1983-06-08
IT7951095A0 (en) 1979-12-14
DE2949491C2 (en) 1988-10-27
CY1321A (en) 1986-06-27
NL7909024A (en) 1980-06-20
FR2444681B1 (en) 1982-10-29
SE445219B (en) 1986-06-09
CH639659A5 (en) 1983-11-30
SG97585G (en) 1986-07-18
HK16086A (en) 1986-03-14
SE7910188L (en) 1980-06-19
JPS5583783A (en) 1980-06-24
NL193066C (en) 1998-09-08
JPH0369910B2 (en) 1991-11-05
NL990014I1 (en) 1999-07-01
MY8500130A (en) 1985-12-31
ZA796842B (en) 1981-07-29
DE2949491A1 (en) 1980-06-26
BE880591A (en) 1980-06-13
AU5389679A (en) 1980-06-26
FR2444681A1 (en) 1980-07-18
GB2037766A (en) 1980-07-16
KE3593A (en) 1986-02-07
GB2037766B (en) 1983-02-16
IE49496B1 (en) 1985-10-16
AU536055B2 (en) 1984-04-19

Similar Documents

Publication Publication Date Title
SE7910188L (en) 1,4-dihydropyridine
AU4083589A (en) ((1-lower alkyloxy-1-methyl)ethoxy)amines
HUT36328A (en) Fungicides containing 7-amino-azolo /1,5-a/ pyrimidine-derivatives and process for the production of the agents
ATE96426T1 (en) DIPHENYL UREA DERIVATIVES.
ATE36707T1 (en) NEW AMINOPYRAZOLINONES, THEIR PREPARATION AND USE.
BG30474A3 (en) METHOD FOR THE PREPARATION OF 6-P-PROPYL-8-METHOXYMETHYL-OR- METHYLMERCAPTOMETHYLERGOLINES AND RELATED COMPOUNDS
HUT49860A (en) Process for producing benzamide-type protease inhibitors
ATE36714T1 (en) BETA-LACTA ANTIBIOTICS, PROCESS FOR THEIR MANUFACTURE AND AGENTS CONTAINING THEM.
ATE78488T1 (en) PROCESS FOR THE PREPARATION OF ANDROSTA-1,4-DIEN3,17-DIONE-METHYLENE DERIVATIVES.
ATE66609T1 (en) OXAZAPHOSPHORINE SOLUTIONS WITH IMPROVED STABILITY AND PROCESSES FOR THEIR PREPARATION.
DE3579004D1 (en) NEW SULFOBETAINE OF AMMONIOCARBONIC ACID AMIDES AND METHOD FOR THE PRODUCTION THEREOF.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
SE7910151L (en) BENZOXADIAZOLES AND BENSTIADIAZOLES
ATE42091T1 (en) N-(6-METHOXY-5(PERFLUORALKYL)-1-NAPHTHOYL)-NMETHYLGLYCINE AND THEIR THIONAPHTHOYLANALOGS.
PT77757B (en) Chemical process
DE3669508D1 (en) BRIDGE REAGENT, METHOD FOR THE PRODUCTION THEREOF AND ITS USE.
HUT42443A (en) Process for preparing novel dihydropyridine derivatives
DE3580698D1 (en) METHOD FOR PRODUCING 4 (3H) -QUINAZOLINONES.
ES8602645A1 (en) Substituted derivatives of phenoxypropionic acid.
FI842639L (en) ACYLDERIVAT AV 1,4,3,6-DIANHYDRO- HEXITOL.
DE69408128D1 (en) WATER CHATHRATE OF PIPERAZINYLPYRIDINE
ATE32870T1 (en) POTASSIUM PERBORATE HYDRATE AND PROCESS FOR ITS PRODUCTION.
FI850401L (en) MAETTADE TRICYCLISKA KVAEVEHALTIGA DIONER SAOSOM MEDEL FOER AKTIVERING AV FATTNINGSFOEREMAOGAN.

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 58/93:19930628

SPCG Supplementary protection certificate granted

Free format text: SPC 58/93 EXPIRES:20040104

MK9A Patent expired